Home ›
NPI 1881904829
NPI deactivated
1881904829
1881904829 was paid $237.34 by Medicaid between Jan 2018 and Jan 2020, across 254 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 40% of everything it billed.
33Billing provider info1881904829
33aNPI1881904829
33bProvider type—
28Total paid$237.34
24GClaims1,247,144
24DCodes billed254
24AFirst – last monthJan 2018 – Jan 2020
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 412,086 | $237.34 | |
| 2019 | 826,433 | $0.00 | |
| 2020 | 8,625 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 40% | 151,743 | 142,275 | $95.63 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 27% | 13,881 | 12,517 | $63.85 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 26% | 33,657 | 32,225 | $62.24 |
| 85730 | 6.6% | 3,556 | 3,476 | $15.62 | |
| 83615 | 0% | 1,599 | 1,494 | $0.00 | |
| 82105 | 0% | 2,272 | 2,237 | $0.00 | |
| 84270 | 0% | 675 | 667 | $0.00 | |
| 86800 | 0% | 1,030 | 1,025 | $0.00 | |
| 82952 | 0% | 1,016 | 1,015 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 33,639 | 32,225 | $0.00 |
| 82378 | 0% | 1,258 | 1,155 | $0.00 | |
| 84154 | 0% | 1,102 | 1,097 | $0.00 |
242 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 15,761 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 40,821 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 8,975 | $0.00 |
| 82040 | 0% | 723 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 69,438 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 7,101 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 1,057 | $0.00 |
| 82150 | 0% | 1,251 | $0.00 | |
| 87205 | 0% | 902 | $0.00 | |
| 84144 | 0% | 607 | $0.00 | |
| 87906 | 0% | 100 | $0.00 | |
| 86300 | 0% | 562 | $0.00 | |
| 81001 | 0% | 30,140 | $0.00 | |
| 82607 | 0% | 10,799 | $0.00 | |
| 86317 | 0% | 2,442 | $0.00 | |
| 83021 | 0% | 4,753 | $0.00 | |
| 36416 | 0% | 616 | $0.00 | |
| 86901 | 0% | 903 | $0.00 | |
| 87070 | 0% | 3,712 | $0.00 | |
| 87077 | 0% | 3,538 | $0.00 | |
| 86664 | 0% | 186 | $0.00 | |
| 86762 | 0% | 1,596 | $0.00 | |
| 86376 | 0% | 1,650 | $0.00 | |
| 86704 | 0% | 6,667 | $0.00 | |
| 80055 | 0% | 28 | $0.00 | |
| 83014 | 0% | 3,232 | $0.00 | |
| 88142 | 0% | 3,974 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 17,268 | $0.00 |
| 82550 | 0% | 1,159 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 6,258 | $0.00 |
| 84075 | 0% | 845 | $0.00 | |
| 86141 | 0% | 1,258 | $0.00 | |
| 83550 | 0% | 6,894 | $0.00 | |
| 84132 | 0% | 392 | $0.00 | |
| 82043 | 0% | 15,669 | $0.00 | |
| 83880 | 0% | 1,017 | $0.00 | |
| 80197 | 0% | 529 | $0.00 | |
| 81327 | 0% | 1,563 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 12,617 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 61,929 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 31,343 | $0.00 |
| 84479 | 0% | 2,099 | $0.00 | |
| 86706 | 0% | 7,841 | $0.00 | |
| 80178 | 0% | 727 | $0.00 | |
| 86160 | 0% | 798 | $0.00 | |
| 88141 | 0% | 1,705 | $0.00 | |
| 86695 | 0% | 2,176 | $0.00 | |
| 86780 | 0% | 879 | $0.00 | |
| 85027 | 0% | 23,970 | $0.00 | |
| 86140 | 0% | 4,929 | $0.00 | |
| 83520 | 0% | 1,114 | $0.00 | |
| 85018 | 0% | 4,452 | $0.00 | |
| 86592 | 0% | 19,335 | $0.00 | |
| 85652 | 0% | 7,091 | $0.00 | |
| 86304 | 0% | 911 | $0.00 | |
| 87046 | 0% | 1,138 | $0.00 | |
| 86803 | 0% | 16,708 | $0.00 | |
| 87350 | 0% | 424 | $0.00 | |
| 84402 | 0% | 1,302 | $0.00 | |
| 87147 | 0% | 2,043 | $0.00 | |
| 87510 | 0% | 92 | $0.00 | |
| 84480 | 0% | 1,586 | $0.00 | |
| 82670 | 0% | 1,289 | $0.00 | |
| 83090 | 0% | 367 | $0.00 | |
| 82950 | 0% | 5,078 | $0.00 | |
| 87340 | 0% | 11,320 | $0.00 | |
| 87529 | 0% | 123 | $0.00 | |
| 83735 | 0% | 2,576 | $0.00 | |
| 84153 | 0% | 6,991 | $0.00 | |
| 87255 | 0% | 116 | $0.00 | |
| 82784 | 0% | 1,602 | $0.00 | |
| 87517 | 0% | 1,650 | $0.00 | |
| 80081 | 0% | 4,976 | $0.00 | |
| 86850 | 0% | 560 | $0.00 | |
| 82951 | 0% | 1,724 | $0.00 | |
| 87088 | 0% | 11,792 | $0.00 | |
| 80050 | General health panel | 0% | 27,313 | $0.00 |
| 80069 | 0% | 3,579 | $0.00 | |
| 82435 | 0% | 44 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 12,297 | $0.00 |
| 86593 | 0% | 910 | $0.00 | |
| 84703 | 0% | 1,247 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 54,385 | $0.00 |
| 84436 | 0% | 3,283 | $0.00 | |
| 83519 | 0% | 53 | $0.00 | |
| 87081 | 0% | 5,835 | $0.00 | |
| 86255 | 0% | 690 | $0.00 | |
| 82746 | 0% | 6,855 | $0.00 | |
| 83704 | 0% | 601 | $0.00 | |
| 86225 | 0% | 983 | $0.00 | |
| 81596 | 0% | 362 | $0.00 | |
| 83002 | 0% | 1,971 | $0.00 | |
| 82024 | 0% | 12 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 3,168 | $0.00 |
| 82533 | 0% | 180 | $0.00 | |
| 82728 | 0% | 11,167 | $0.00 | |
| 83001 | 0% | 2,733 | $0.00 | |
| 87625 | 0% | 251 | $0.00 | |
| 87536 | 0% | 1,984 | $0.00 | |
| 83883 | 0% | 162 | $0.00 | |
| 80051 | 0% | 51 | $0.00 | |
| 83690 | 0% | 1,808 | $0.00 | |
| 83921 | 0% | 447 | $0.00 | |
| 86361 | 0% | 1,521 | $0.00 | |
| 86707 | 0% | 415 | $0.00 | |
| 84478 | 0% | 294 | $0.00 | |
| 86021 | 0% | 100 | $0.00 | |
| 83498 | 0% | 144 | $0.00 | |
| 86308 | 0% | 43 | $0.00 | |
| 82390 | 0% | 43 | $0.00 | |
| 86301 | 0% | 42 | $0.00 | |
| 86812 | 0% | 55 | $0.00 | |
| 87480 | 0% | 92 | $0.00 | |
| 85379 | 0% | 13 | $0.00 | |
| 81229 | 0% | 39 | $0.00 | |
| 86060 | 0% | 27 | $0.00 | |
| 80177 | 0% | 136 | $0.00 | |
| 87900 | 0% | 132 | $0.00 | |
| 87521 | Neg quan hep c or qual rna | 0% | 14 | $0.00 |
| 87449 | 0% | 85 | $0.00 | |
| 82330 | 0% | 40 | $0.00 | |
| 83993 | 0% | 53 | $0.00 | |
| 82672 | 0% | 135 | $0.00 | |
| 83010 | 0% | 12 | $0.00 | |
| 82164 | 0% | 12 | $0.00 | |
| 82525 | 0% | 12 | $0.00 | |
| 81015 | 0% | 66 | $0.00 | |
| 84134 | 0% | 13 | $0.00 | |
| 83655 | 0% | 9,216 | $0.00 | |
| 86480 | 0% | 5,070 | $0.00 | |
| 84520 | 0% | 641 | $0.00 | |
| 82542 | 0% | 14 | $0.00 | |
| 82274 | 0% | 8,323 | $0.00 | |
| 83540 | 0% | 8,805 | $0.00 | |
| 86900 | 0% | 850 | $0.00 | |
| 82747 | 0% | 460 | $0.00 | |
| 80076 | 0% | 2,784 | $0.00 | |
| 82570 | 0% | 17,033 | $0.00 | |
| 83695 | 0% | 628 | $0.00 | |
| 82947 | 0% | 2,862 | $0.00 | |
| 84156 | 0% | 1,593 | $0.00 | |
| 87177 | 0% | 1,796 | $0.00 | |
| 86038 | 0% | 4,534 | $0.00 | |
| 82977 | 0% | 1,242 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 1,978 | $0.00 |
| 83013 | 0% | 4,383 | $0.00 | |
| 84439 | 0% | 16,246 | $0.00 | |
| 86003 | 0% | 4,085 | $0.00 | |
| 85014 | 0% | 1,517 | $0.00 | |
| 84165 | 0% | 354 | $0.00 | |
| 86235 | 0% | 1,080 | $0.00 | |
| 84403 | 0% | 3,637 | $0.00 | |
| 86787 | 0% | 1,614 | $0.00 | |
| 82652 | 0% | 1,424 | $0.00 | |
| 86709 | 0% | 1,177 | $0.00 | |
| 84481 | 0% | 3,201 | $0.00 | |
| 84146 | 0% | 2,481 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 1,758 | $0.00 |
| 99001 | 0% | 2,151 | $0.00 | |
| 85041 | 0% | 790 | $0.00 | |
| 85007 | 0% | 1,284 | $0.00 | |
| 87427 | 0% | 1,120 | $0.00 | |
| 86696 | 0% | 2,308 | $0.00 | |
| 83525 | 0% | 3,252 | $0.00 | |
| 85610 | 0% | 8,690 | $0.00 | |
| 84100 | 0% | 2,000 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 6,012 | $0.00 |
| 83698 | 0% | 371 | $0.00 | |
| 82627 | 0% | 768 | $0.00 | |
| 83516 | 0% | 1,850 | $0.00 | |
| 84460 | 0% | 4,368 | $0.00 | |
| 84305 | 0% | 80 | $0.00 | |
| 85045 | 0% | 686 | $0.00 | |
| 84425 | 0% | 251 | $0.00 | |
| 87799 | 0% | 16,575 | $0.00 | |
| 86708 | 0% | 6,103 | $0.00 | |
| 82310 | 0% | 649 | $0.00 | |
| 82565 | 0% | 1,496 | $0.00 | |
| 87045 | 0% | 1,205 | $0.00 | |
| 82465 | 0% | 352 | $0.00 | |
| 86008 | 0% | 374 | $0.00 | |
| 84702 | 0% | 3,197 | $0.00 | |
| 87186 | 0% | 4,008 | $0.00 | |
| 86334 | 0% | 197 | $0.00 | |
| 86039 | 0% | 691 | $0.00 | |
| 86665 | 0% | 269 | $0.00 | |
| 86200 | 0% | 2,012 | $0.00 | |
| 87512 | 0% | 6,196 | $0.00 | |
| 0001M | 0% | 55 | $0.00 | |
| 86147 | 0% | 73 | $0.00 | |
| 81025 | 0% | 556 | $0.00 | |
| 86735 | 0% | 1,333 | $0.00 | |
| 86765 | 0% | 1,294 | $0.00 | |
| 83970 | 0% | 1,817 | $0.00 | |
| 82172 | 0% | 656 | $0.00 | |
| 82785 | 0% | 3,181 | $0.00 | |
| 89055 | 0% | 25 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 57 | $0.00 |
| 87902 | 0% | 908 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 14,143 | $0.00 |
| 82248 | 0% | 2,877 | $0.00 | |
| 87209 | 0% | 1,797 | $0.00 | |
| 87338 | 0% | 2,203 | $0.00 | |
| 87075 | 0% | 789 | $0.00 | |
| 80074 | 0% | 3,754 | $0.00 | |
| 81257 | 0% | 175 | $0.00 | |
| 80061 | Lipid panel | 0% | 77,105 | $0.00 |
| 84450 | 0% | 3,707 | $0.00 | |
| 82247 | 0% | 1,739 | $0.00 | |
| 84550 | 0% | 5,382 | $0.00 | |
| 81003 | 0% | 2,571 | $0.00 | |
| 86162 | 0% | 15 | $0.00 | |
| 86705 | 0% | 272 | $0.00 | |
| 85060 | 0% | 226 | $0.00 | |
| 80164 | 0% | 1,116 | $0.00 | |
| 82140 | 0% | 107 | $0.00 | |
| 80500 | 0% | 110 | $0.00 | |
| 84155 | 0% | 168 | $0.00 | |
| 86360 | 0% | 220 | $0.00 | |
| 85048 | 0% | 136 | $0.00 | |
| 84445 | 0% | 166 | $0.00 | |
| 83721 | 0% | 257 | $0.00 | |
| 87660 | 0% | 92 | $0.00 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 54 | $0.00 |
| 82107 | 0% | 43 | $0.00 | |
| 87150 | 0% | 84 | $0.00 | |
| 86431 | 0% | 3,629 | $0.00 | |
| 87324 | 0% | 80 | $0.00 | |
| 84295 | 0% | 105 | $0.00 | |
| 87329 | 0% | 269 | $0.00 | |
| 82397 | 0% | 139 | $0.00 | |
| 84466 | 0% | 31 | $0.00 | |
| 87901 | 0% | 132 | $0.00 | |
| 87481 | 0% | 76 | $0.00 | |
| 87076 | 0% | 65 | $0.00 | |
| 84207 | 0% | 46 | $0.00 | |
| 82239 | 0% | 15 | $0.00 | |
| 82595 | 0% | 18 | $0.00 | |
| 84630 | 0% | 12 | $0.00 | |
| 85613 | 0% | 46 | $0.00 | |
| 86146 | 0% | 18 | $0.00 | |
| 86618 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.